Medical emergency? Call 911. · Educational portal — not medical or legal advice · Disclaimer

Medication guide

Nitroglycerin: uses, appearance and warnings

What the official FDA label says Nitroglycerin is used for, what it looks like, and its most important warnings — in plain English, with the label text one click away.
Nitrate VasodilatorPrescription label

Uses

What the official label says Nitroglycerin is used for

The FDA label for Nitroglycerin states:

Nitroglycerin Extended-Release Capsules are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of oral nitroglycerin is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.
Read the label's “Indications and usage” section (verbatim)
Nitroglycerin Extended-Release Capsules are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of oral nitroglycerin is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.

Names & forms

Brand names, forms and strengths

Brand names (from RxNorm; not every brand is still sold): Gonitro, Nitro-Bid, Nitro-Dur, NitroMist, Nitrolingual, Nitrostat, Rectiv.

Generic name: nitroglycerin · RxNorm ID (RxCUI): 4917

Forms and strengths of Nitroglycerin listed in RxNorm
FormStrengths listed in RxNorm
Buccal Tablet2 MG, 3 MG, 5 MG
Extended Release Oral Capsule2.5 MG, 6.5 MG, 9 MG
Injectable Solution1 MG/ML
Injection0.1 MG/ML, 0.2 MG/ML, 0.4 MG/ML, 5 MG/ML
Mucosal Spray0.4 MG/ACTUAT
Oral Capsule6.5 MG, 9 MG
Rectal Ointment0.002 MG/MG, 0.004 MG/MG
Sublingual Powder0.4 MG
Sublingual Tablet0.3 MG, 0.4 MG, 0.5 MG, 0.6 MG
Sustained Release Buccal Tablet1 MG, 1.5 MG, 2 MG, 3 MG, 5 MG
Topical Ointment0.02 MG/MG
Transdermal System0.1 MG/HR, 0.2 MG/HR, 0.3 MG/HR, 0.4 MG/HR, 0.6 MG/HR, 0.8 MG/HR

Strengths are listed so you can recognise a product — not as dosing information. Only your prescriber can decide what is right for you.

Appearance

What Nitroglycerin looks like

Illustration: clear capsule capsule, imprint TCL 1221TCL 1221

nitroglycerin 2.5 mg
TIME CAP LABORATORIES, INC

Illustration: YELLOW capsule capsule, imprint TCL 1222TCL 1222

nitroglycerin 6.5 mg
TIME CAP LABORATORIES, INC

Illustration: YELLOW capsule capsule, imprint TCL 1223TCL 1223

nitroglycerin 9 mg
TIME CAP LABORATORIES, INC

Illustration based on label data — not a photo; appearance varies by manufacturer. Confirm with your pharmacist.
Appearance of Nitroglycerin products from DailyMed product data
StrengthFormColourShapeSizeImprintScoreLabeler
nitroglycerin 2.5 mgcapsulepinkwhite“clear”capsule7 mmTCL · 12211TIME CAP LABORATORIES, INC
nitroglycerin 6.5 mgcapsuleblueyellow“YELLOW”capsule8 mmTCL · 12221TIME CAP LABORATORIES, INC
nitroglycerin 9 mgcapsulegreenyellow“YELLOW”capsule9 mmTCL · 12231TIME CAP LABORATORIES, INC

From the product data in each manufacturer's label on DailyMed. Many companies make Nitroglycerin, so your medicine may look different from any shown here. If a pill looks unfamiliar, ask your pharmacist before taking it.

Read the label's “How supplied” section (verbatim)
Nitroglycerin Extended-Release Capsules, 2.5 mg (Pink and Clear, imprinted TCL 1221) in 60 and 100 count bottles. HOW SUPPLIED Nitroglycerin Extended- Release Capsules, 6.5 mg (Blue and Yellow, imprinted TCL 1222) in 60 and 100 count bottles. HOW SUPPLIED Nitroglycerin Extended-Release Capsules, 9 mg (Green and Yellow, imprinted TCL 1223) in 60 and 100 count bottles. Rx only

Safety

Important warnings for Nitroglycerin

Amplification of the vasodilatory effects of nitroglycerin by phosphodiesterase inhibitors can result in severe hypotension. The time course and dose dependence of this interaction have not been studied. Appropriate supportive care has not been studied, but it seems reasonable to treat this as a nitrate overdose, with elevation of the extremities and with central volume expansion. …

Contraindications — who should not use it (verbatim)
Allergic reactions to organic nitrates are extremely rare, but they do occur. Nitroglycerin is contraindicated in patients who are allergic to it. Do not use nitroglycerin extended-release capsules in patients who are taking phosphodiesterase inhibitors (such as sildenafil, tadalafil, or vardenafil) for erectile dysfunction or pulmonary arterial hypertension.Concomitant use can cause severe drops in blood pressure. Do not use nitroglycerin extended-release capsules in patients who are taking soluble guanylate cyclase stimulators (such as riociguat). Concomitant use can cause hypotension.
Warnings and precautions (verbatim excerpt)
Amplification of the vasodilatory effects of nitroglycerin by phosphodiesterase inhibitors can result in severe hypotension. The time course and dose dependence of this interaction have not been studied. Appropriate supportive care has not been studied, but it seems reasonable to treat this as a nitrate overdose, with elevation of the extremities and with central volume expansion. The benefits of oral nitroglycerin in patients with acute myocardial infarction or congestive heart failure have not been established. If one elects to use nitroglycerin in these conditions, careful clinical or hemodynamic monitoring must be used to avoid the hazards of hypotension and tachycardia. Because the effects at capsules are so difficult to terminate rapidly, that are not recommended in these settings. PRECAUTIONS: General: Severe hypotension, particularly with upright posture, may occur with even small doses of nitroglycerin. This drug should therefore be used with caution in patients who may be volume depleted or who, for whatever reason, are already hypotensive. Hypotension induced by nitroglycerin may be accompanied by paradoxical bradycardia and increased angina pectoris. Nitrate therapy may aggravate the angina caused by hypertrophic cardiomyopathy. As tolerance in other forms of nitroglycerin develops, the effect of sublingual nitroglycerin on exercise tolerance, although still observable, is somewhat blunted. In industrial workers who have had long-term exposure to unknown (presumably high) doses of organic nitrates, tolerance clearly occurs. Chest pain, acute myocardial infarction, and even sudden death have occurred during temporary withdrawal of nitrates from these workers, demonstrating the existence of true physical dependence. Some clinical trials in angina patients have provided nitroglycerin for about 12 continuous hours of every 24-hour day. During the nitrate-free intervals in some of these trials, anginal attacks have been more easily provoked than before treatment, and patients have demonstrated hemodynamic rebound and decreased exercise tolerance. The importance of these observations to the routine, clinical use at oral nitroglycerin is not known.
Side effects — opening of the label's adverse reactions section
Adverse reactions to nitroglycerin are generally dose-related, and almost all of these reactions are the result of nitroglycerin's activity as a vasodilator. Headache, which may be severe, is the most commonly reported side effect. Headache may be recurrent with each daily dose, especially at higher doses. Transient episodes of lightheadedness, occasionally related to blood pressure changes, may also occur. Hypotension occurs infrequently, but in some patients may be severe enough to warrant discontinuation of therapy. Syncope, crescendo angina, and rebound hypertension have been reported but are uncommon. Allergic reactions to nitroglycerin are also uncommon, and the great majority of those reported have been cases of contact dermatitis or fixed drug eruptions in patients receiving nitroglycerin in ointments or patches. …
Drug interactions — opening of the label's section
The vasodilating effects of nitroglycerin may be additive with those of other vasodilators. Alcohol, in particular, has been found to exhibit additive effects of this variety. Marked symptomatic orthostatic hypotension has been reported when calcium channel blockers and organic nitrates were used in combination. Dose adjustments of either class of agents may be necessary.

This is not a complete list of warnings or side effects. Read the full label and talk to your prescriber or pharmacist. To report a side effect to the FDA, use MedWatch.

Resources

If you were hurt at work

Whether a medicine is right for you is a decision for your prescriber. If you were injured on the job, these educational guides explain the next steps and who can help.

Sources

Label text is quoted from the TIME CAP LABORATORIES, INC label (label version effective May 18, 2026), retrieved October 20, 2026. Other manufacturers' labels for the same medicine may differ in wording.

If anything here differs from the label that came with your medicine, follow your label and your pharmacist.

Prescriptions.plus is an educational portal. We are not a pharmacy, law firm, medical provider, insurer or claims administrator, and nothing here is medical or legal advice. Educational purposes only. This page does not tell you whether to take a medicine or how much to take. Medical emergency? Call 911. Poison emergency: call Poison Control at 1-800-222-1222.